REIMAGINE CELLULAR IMAGING
The Next Revolution in Imaging is Here.
Enspectra Health is leading innovation in imaging with the VIO™ System. This hand-held technology digitizes cell images non-invasively and in real-time, providing physicians with valuable cellular insights.
VIO combines novel multiphoton laser scanning with reflectance confocal microscopy to instantly generate high resolution digital images of live cells without the need for an incision.
The Enspectra Health imaging technology is being developed to address numerous clinical needs. The first application of this platform technology is skin health.
The VIO System is cleared by the US FDA. It is intended to acquire, store, retrieve, display and transfer in vivo images of tissue - including blood vessels, collagen, pigment, stratum corneum, hair shafts or follicles, solar elastosis, hyperkeratosis, atypia, and epidermal disarray - in and through epidermis for review by physicians to assist in forming a clinical judgment. Physicians who interpret VIO System images must have dermatology or pathology medical qualifications with skin histology assessment training.
"Enspectra Health's mission is to redefine how disease is diagnosed by leveraging revolutionary imaging and machine learning technology. We want to arm physicians with the cellular data that they need, at the point of care in real-time, to transform patient care."
- Gabriel Sanchez, CEO Enspectra Health
Advancing Intelligent Imaging
LEADERSHIP
GABRIEL SANCHEZ
CoFounder & CEO
Leveraging his extensive experience innovating in the fields of optics and electromechanical devices, Gabriel serves as the visionary for Enspectra Health. Working with a team of experts, Gabriel is leading the rapid advancement and development of Enspectra's multiphoton imaging device to evaluate a broad spectrum of skin conditions.
BILL BEASLEY
President & COO
Bill has over 20 years of experience in medical device executive management, operations, manufacturing, supply chain, and infrastructure. He has supported product launches and scale up activities at several device startups, leading to acquisitions by companies such as Hologic, Medtronic and Stryker Corporation.
GRACE KAO LI
VP of Quality and Regulatory
Grace is a seasoned quality and regulatory leader with over 20 years of experience building high-functioning teams and compliance operations in the medical device and digital health industries. She has driven complex program strategies in exceptionally dynamic environments, ranging from startups to Fortune 100 companies.
.jpg)
SHELLEY MARWAH
VP of Commercial Strategy
Shelley brings over 20 years of experience commercializing early-stage medical and digital health technologies. She is a proven leader with significant industry expertise in marketing, business development, strategic partnerships, and leading cross-functional teams to drive growth.
MARK SCHNITZER
CoFounder
Mark is a professor of biology and applied physics at Stanford University who has pioneered microendoscopy for in vivo imaging. An expert in the custom design of optical instrumentation and multiphoton imaging techniques, his research at Stanford has spawned multiple scientific breakthroughs.
NEWS
PARTNERS
INVESTORS
CONTACT US
2495 Hospital Drive, Suite 300
Mountain View, CA 94040
(650) 480-6022
